Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Clinical Chemistry and Laboratory Medicine|August 8, 2012
Assessing the utility of whole genome amplified DNA as a template for DMET Plus arrayYi Jing He, Anne D Misher, William Irvin, et al.
Asia-Pacific Journal of Clinical Oncology|February 22, 2011
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>CEkkaphon Metharom, Peter Galettis, Susan Manners, et al.
Nucleic Acids Research|December 25, 1993
Cloning and characterisation of the Schizosaccharomyces pombe rad8 gene, a member of the SNF2 helicase familyC L Doe, J M Murray, M Shayeghi, et al.
Journal of Genetic Counseling|May 7, 2011
Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility familiesJune A Peters, Regina Kenen, Lindsey M Hoskins, et al.
Journal of Psychosocial Oncology|June 5, 2018
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutationsAllison Werner-Lin, Anne L Ersig, Rebecca Mueller, et al.
Pharmacogenomics|June 18, 2015
Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groupsYijing He, Janelle M Hoskins, Scott Clark, et al.
American Journal of Perinatology|January 1, 1984
Perinatal factors that influence the incidence of subependymal and intraventricular hemorrhage in low birthweight infantsT Dolfin, M B Skidmore, K W Fong, et al.
Biochemical Pharmacology|February 7, 2006
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cellsM L Holland, J A Panetta, J M Hoskins, et al.
The Pharmacogenomics Journal|July 22, 2015
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trialY J He, S J Winham, J M Hoskins, et al.
Clinical Pharmacology and Therapeutics|January 8, 2005
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancerMark Wong, Scott Evans, Laurent P Rivory, et al.
Pageof 9